GAO’s Problematic Analysis Paints Wrong 340B Picture
Recently, the federal government Accountability Office issued an essential number of the 340B program. GAO interviewed 61 stakeholders within the program regarding ability to create revenue and distribute drugs. GAO also examined the adequacy of federal oversight within the program....
